NCT07671846 Patient Anxiety During Magnetic Resonance Imaging
| NCT ID | NCT07671846 |
| Status | Recruiting |
| Phase | — |
| Sponsor | European Institute of Oncology |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 175 participants |
| Start Date | 2026-05-06 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 175 participants in total. It began in 2026-05-06 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a cross-sectional validation project that aims to translate the MRI-Anxiety Questionnaire (MRI-AQ) into Italian and adapt it culturally for cancer patients undergoing whole-body MRI. The protocol will recruit 175 adult patients at the European Institute of Oncology, use a forward-backward translation process, and evaluate the Italian version with the MRI-AQ itself plus the MRI Fear Survey Schedule (MRI-FSS). The main statistical goal is to show that the Italian version is not inferior to the original in terms of internal consistency. The ultimate purpose is to provide a specific, validated tool for measuring MRI-related anxiety in Italian oncology patients.
Eligibility Criteria
Inclusion Criteria: * Cancer patients who will perform a WB-MRI in their clinical path * Age ≥ 18 years * Patients able to speak and read the local language(s) fluently. * Patients with no concomitant neurological or psychiatric disorders. * Acceptance and signature of informed consent Exclusion Criteria: * Absolute contraindication to WB-MRI * Previous cancer-related medical treatments or other treatments that could have altered patients' cognition
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07671846 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07671846 currently recruiting?
Yes, NCT07671846 is actively recruiting participants. Contact the research team at giuseppe.petralia@ieo.it for enrollment information.
Where is the NCT07671846 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07671846 clinical trial?
NCT07671846 is sponsored by European Institute of Oncology. The trial plans to enroll 175 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.